Universal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Scholar Rock Holding Corporation (NASDAQ:SRRK)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired 15,942 shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) valued at approximately $513,000 in the first quarter.
• Insider Akshay Vaishnaw sold 6,750 shares, while Director Joshua Reed sold 5,400 shares, totaling 93,654 shares sold by insiders worth over $3.1 million in the past three months.
• Analysts have rated Scholar Rock with an average buy rating and set a price target averaging around $44.14, indicating a positive outlook for the company's stock.

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 15,942 shares of the company's stock, valued at approximately $513,000.

A number of other large investors also recently modified their holdings of SRRK. CWM LLC lifted its stake in Scholar Rock by 152.8% in the 1st quarter. CWM LLC now owns 996 shares of the company's stock valued at $32,000 after purchasing an additional 602 shares during the last quarter. GF Fund Management CO. LTD. raised its holdings in Scholar Rock by 21.9% in the 1st quarter. GF Fund Management CO. LTD. now owns 2,396 shares of the company's stock valued at $77,000 after acquiring an additional 430 shares during the period. Tema Etfs LLC bought a new position in Scholar Rock in the 4th quarter valued at about $209,000. Mackenzie Financial Corp bought a new position in Scholar Rock in the 4th quarter valued at about $212,000. Finally, Farallon Capital Management LLC bought a new position in Scholar Rock in the 4th quarter valued at about $303,000. 91.08% of the stock is currently owned by institutional investors and hedge funds.

Scholar Rock Trading Down 5.3%

Shares of SRRK traded down $1.96 during trading hours on Wednesday, reaching $35.02. 4,052,556 shares of the company traded hands, compared to its average volume of 1,200,425. Scholar Rock Holding Corporation has a 12 month low of $6.76 and a 12 month high of $46.98. The company has a market capitalization of $3.32 billion, a price-to-earnings ratio of -13.97 and a beta of 0.48. The company's fifty day moving average price is $35.54 and its two-hundred day moving average price is $34.70. The company has a quick ratio of 10.25, a current ratio of 10.25 and a debt-to-equity ratio of 0.16.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.68) by ($0.30). During the same quarter in the prior year, the firm earned ($0.60) EPS. Equities research analysts predict that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current fiscal year.

Insider Activity at Scholar Rock

In other news, insider Mo Qatanani sold 24,066 shares of the company's stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $34.44, for a total value of $828,833.04. Following the transaction, the insider directly owned 115,495 shares in the company, valued at approximately $3,977,647.80. This represents a 17.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Akshay Vaishnaw sold 6,750 shares of the company's stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $29.72, for a total transaction of $200,610.00. Following the completion of the transaction, the insider owned 616,205 shares in the company, valued at approximately $18,313,612.60. The trade was a 1.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 93,654 shares of company stock valued at $3,101,811 over the last quarter. 13.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on SRRK shares. Cantor Fitzgerald initiated coverage on shares of Scholar Rock in a report on Thursday, July 17th. They set an "overweight" rating on the stock. Raymond James Financial set a $53.00 price target on shares of Scholar Rock and gave the company a "strong-buy" rating in a research note on Wednesday, July 30th. Wedbush reiterated an "outperform" rating and issued a $50.00 target price on shares of Scholar Rock in a research note on Wednesday, June 18th. Finally, Lifesci Capital upgraded shares of Scholar Rock to a "strong-buy" rating in a research note on Tuesday, June 3rd. Seven equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Scholar Rock presently has a consensus rating of "Buy" and a consensus price target of $44.14.

Scholar Rock Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.